Epstein Secrets

rump administration." In addition, The Hill (11/15, Williams, 2.98M) reports Stephen Moore, an economist and adviser to Trump, in an interview with WABC-AM "said the president is `a little grouchy' over the results of the election," but "expressed optimism that Trump would get reelected despite almost e

g maker to release an early analysis of vaccine trial data," could apply for the FDA's emergency authorization "as early as this week." BioNTech CEO Ugur Sahin: "If everything continues to go well, we will start to deliver the vaccine end of this year, beginning next year." However, Lopez added, "Supplying

rump administration." In addition, The Hill (11/15, Williams, 2.98M) reports Stephen Moore, an economist and adviser to Trump, in an interview with WABC-AM "said the president is `a little grouchy' over the results of the election," but "expressed optimism that Trump would get reelected despite almost e

g maker to release an early analysis of vaccine trial data," could apply for the FDA's emergency authorization "as early as this week." BioNTech CEO Ugur Sahin: "If everything continues to go well, we will start to deliver the vaccine end of this year, beginning next year." However, Lopez added, "Supplying

rump administration." In addition, The Hill (11/15, Williams, 2.98M) reports Stephen Moore, an economist and adviser to Trump, in an interview with WABC-AM "said the president is `a little grouchy' over the results of the election," but "expressed optimism that Trump would get reelected despite almost e

g maker to release an early analysis of vaccine trial data," could apply for the FDA's emergency authorization "as early as this week." BioNTech CEO Ugur Sahin: "If everything continues to go well, we will start to deliver the vaccine end of this year, beginning next year." However, Lopez added, "Supplying